THE DEAL, AT A GLANCE
From the announcementCORE Biomedicine
01Who is involvedBacked by UTokyo Innovation Platform Co, InnoPinnacle Fund, Mitsubishi UFJ Capital CoFrom the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗02What happenedCORE Biomedicine raised $21M Series A, announced 2026-07-28From the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗03Why it mattersCORE Biomedicine's $21 Million Series A financing and AMED grant award support development of precision oncology medicines that go beyond genomics.From the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗Click a part to explore its evidence. Unsupported imagery is withheld rather than guessed.Original record source ↗
CORE Biomedicine · Financing Record
Explore source-linked visual explanations for CORE Biomedicine. Unsupported claims are withheld while source review continues.
Record 9130 · Recorded date: 2026-07-28
Explore company records →